CGTX · Cognition Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Ogden CAP Associates, LLC 10% Owner | ▼ Sell | Open Market | 2,210,377 Shares held | 10/13/2021 | View profile |
| Lisa Ricciardi CEO & President | ▲ Buy | Open Market | 1,715,851 Shares held | 4/16/2026 | View profile |
| Anthony Caggiano Chief Medical Officer | ▲ Buy | Open Market | 874,906 Shares held | 4/16/2026 | View profile |
| John Brendan Doyle Chief Financial Officer | ▼ Sell | Tax Withholding | 618,942 Shares held | 5/1/2026 | View profile |
| Breedlove Mark H. Director | ▼ Sell | Open Market | 404,439 Shares held | 10/13/2021 | View profile |
| Peggy Wallace Director | ▲ Buy | Grant | 111,461 Shares held | 6/17/2026 | View profile |
| Ellen B. Richstone Director | ▲ Buy | Grant | 83,500 Shares held | 6/17/2026 | View profile |
| Aaron G.L. Fletcher Director | ▲ Buy | Grant | 81,229 Shares held | 6/17/2026 | View profile |
| Jack A. Khattar President, CEO | ▲ Buy | Grant | 73,500 Shares held | 6/17/2026 | View profile |
| Brett P. Monia Chief Executive Officer | ▲ Buy | Grant | 73,500 Shares held | 6/17/2026 | View profile |
| BIOS Memory SPV I, LP 10% Owner | ▼ Sell | Other | 60,065 Shares held | 10/13/2021 | View profile |
| Leslie W. Kreis Director | ▲ Buy | Grant | 48,500 Shares held | 6/18/2025 | View profile |
| O'Brien James Michael Chief Financial Officer | ▲ Buy | Open Market | 5,000 Shares held | 10/13/2021 | View profile |
| Golden Seeds Cognition Therapeutics LLC 10% Owner | ▼ Sell | Other | 0 Shares held | 9/27/2022 | View profile |
Transaction History
| Brett P. Monia | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 |
| Peggy Wallace | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 |
| Ellen B. Richstone | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 |
| Aaron G.L. Fletcher | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 |
| Jack A. Khattar | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 8,567 | $11K | 5/1/2026 |
| John Brendan Doyle | ▲ Buy | Open Market | 10,000 | $11K | 4/16/2026 |
| Lisa Ricciardi | ▲ Buy | Open Market | 9,175 | $10K | 4/16/2026 |
| Anthony Caggiano | ▲ Buy | Open Market | 10,000 | $11K | 4/16/2026 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 5,850 | $7K | 2/15/2026 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 1,560 | $2K | 2/15/2026 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 4,680 | $5K | 2/15/2026 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 51,704 | $53K | 2/4/2026 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 26,921 | $28K | 2/4/2026 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 26,919 | $28K | 2/4/2026 |
| Lisa Ricciardi | ▲ Buy | Grant | 800,000 | $0 | 2/3/2026 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 26,036 | $29K | 2/3/2026 |
| John Brendan Doyle | ▲ Buy | Grant | 200,000 | $0 | 2/3/2026 |
| Anthony Caggiano | ▲ Buy | Grant | 400,000 | $0 | 2/3/2026 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 11,488 | $13K | 2/3/2026 |
| Anthony Caggiano | ▲ Buy | Grant | 65,000 | $0 | 12/18/2025 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 20,280 | $30K | 12/18/2025 |
| John Brendan Doyle | ▲ Buy | Grant | 30,000 | $0 | 12/18/2025 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 9,360 | $14K | 12/18/2025 |
| Lisa Ricciardi | ▲ Buy | Grant | 75,000 | $0 | 12/18/2025 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 23,400 | $35K | 12/18/2025 |
| Aaron G.L. Fletcher | ▲ Buy | Option Exercise | 7,729 | $6K | 9/19/2025 |
| Anthony Caggiano | ▲ Buy | Grant | 65,000 | $0 | 7/29/2025 |
| John Brendan Doyle | ▲ Buy | Grant | 30,000 | $0 | 7/29/2025 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 9,360 | $6K | 7/29/2025 |
| Lisa Ricciardi | ▲ Buy | Grant | 75,000 | $0 | 7/29/2025 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 20,281 | $14K | 7/29/2025 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 23,400 | $16K | 7/29/2025 |
| Leslie W. Kreis | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 |
| Aaron G.L. Fletcher | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 |
| Jack A. Khattar | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 |
| Peggy Wallace | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 |
| Ellen B. Richstone | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 |
| Brett P. Monia | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 9,692 | $4K | 5/1/2025 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 6,619 | $4K | 2/15/2025 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 5,296 | $3K | 2/15/2025 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 1,723 | $1K | 2/15/2025 |
| John Brendan Doyle | ▲ Buy | Grant | 295,000 | $0 | 2/4/2025 |
| Lisa Ricciardi | ▲ Buy | Grant | 631,300 | $0 | 2/4/2025 |
| Anthony Caggiano | ▲ Buy | Grant | 295,000 | $0 | 2/4/2025 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 12,779 | $9K | 2/3/2025 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 28,960 | $19K | 2/3/2025 |
| Lisa Ricciardi | ▲ Buy | Open Market | 38,851 | $30K | 1/31/2025 |
| Peggy Wallace | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 |
| Aaron G.L. Fletcher | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 |
| Leslie W. Kreis | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 |
| Brett P. Monia | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 |
| Jack A. Khattar | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 |
| Ellen B. Richstone | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 |
| John Brendan Doyle | ▼ Sell | Tax Withholding | 8,699 | $17K | 5/1/2024 |
| Lisa Ricciardi | ▲ Buy | Open Market | 5,700 | $10K | 3/14/2024 |
| Lisa Ricciardi | ▲ Buy | Grant | 75,000 | $0 | 2/15/2024 |
| Anthony Caggiano | ▲ Buy | Grant | 60,000 | $0 | 2/15/2024 |
| John Brendan Doyle | ▲ Buy | Grant | 20,000 | $0 | 2/15/2024 |
| Anthony Caggiano | ▼ Sell | Tax Withholding | 12,777 | $29K | 2/3/2024 |
| Lisa Ricciardi | ▼ Sell | Tax Withholding | 27,828 | $64K | 2/3/2024 |
| Leslie W. Kreis | ▲ Buy | Grant | 500,095 | $525K | 11/8/2023 |
| Aaron G.L. Fletcher | ▲ Buy | Grant | 500,095 | $525K | 11/8/2023 |
| Jack A. Khattar | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 |
| Leslie W. Kreis | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 |
| Aaron G.L. Fletcher | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 |
| Brett P. Monia | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 |
| Peggy Wallace | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 |
| Ellen B. Richstone | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 |
| John Brendan Doyle | ▲ Buy | Grant | 109,824 | $0 | 5/1/2023 |
| Anthony Caggiano | ▲ Buy | Grant | 94,406 | $0 | 2/3/2023 |
| Lisa Ricciardi | ▲ Buy | Grant | 213,973 | $0 | 2/3/2023 |
| Ellen B. Richstone | ▲ Buy | Open Market | 10,000 | $27K | 11/29/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 1,973 | $5K | 11/28/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 12,220 | $32K | 11/28/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 1,871 | $5K | 11/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 1,973 | $5K | 11/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 12,220 | $32K | 11/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 1,871 | $5K | 11/28/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 8,722 | $12K | 11/16/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 54,009 | $76K | 11/16/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 8,269 | $12K | 11/16/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 8,722 | $12K | 11/16/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 54,009 | $76K | 11/16/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 8,269 | $12K | 11/16/2022 |
| Lisa Ricciardi | ▲ Buy | Open Market | 12,000 | $16K | 11/15/2022 |
| Peggy Wallace | ▲ Buy | Open Market | 12,500 | $15K | 11/15/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 184,270 | $221K | 11/15/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 1,141,030 | $1.4M | 11/15/2022 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 174,700 | $210K | 11/15/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 184,270 | $221K | 11/15/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 1,141,030 | $1.4M | 11/15/2022 |
| Leslie W. Kreis | ▲ Buy | Open Market | 174,700 | $210K | 11/15/2022 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 2,489,682 | $0 | 9/27/2022 |
| Peggy Wallace | ▼ Sell | Other | 22,461 | $0 | 9/27/2022 |
| Ogden CAP Associates, LLC | ▼ Sell | Other | 103,055 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 418,926 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 34,238 | — | 10/13/2021 |
| Ogden CAP Associates, LLC | ▼ Sell | Other | 272,756 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 24,263 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▲ Buy | Open Market | 23,341 | $280K | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 351,844 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 33,495 | $1K | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Open Market | 90 | $1K | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 41,620 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▲ Buy | Open Market | 22,129 | $266K | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 596,899 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 158,476 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▲ Buy | Open Market | 144,530 | $1.7M | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 34,472 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 25,593 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 1,424,014 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 245,029 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 78,298 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 255,765 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 34,238 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 23,341 | $280K | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 351,844 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 33,495 | $1K | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Open Market | 90 | $1K | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 41,620 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 24,263 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 22,129 | $266K | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 596,899 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 158,476 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▲ Buy | Open Market | 144,530 | $1.7M | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 34,472 | — | 10/13/2021 |
| Aaron G.L. Fletcher | ▼ Sell | Other | 25,593 | — | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 273,321 | — | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 167,721 | — | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 1,237,959 | — | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 486,742 | — | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 12,276 | $393 | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Open Market | 33 | $397 | 10/13/2021 |
| Ogden CAP Associates, LLC | ▼ Sell | Other | 407,916 | — | 10/13/2021 |
| Ogden CAP Associates, LLC | ▼ Sell | Other | 1,263,575 | — | 10/13/2021 |
| Ogden CAP Associates, LLC | ▼ Sell | Other | 135,679 | — | 10/13/2021 |
| Ogden CAP Associates, LLC | ▼ Sell | Other | 27,471 | $879 | 10/13/2021 |
| Ogden CAP Associates, LLC | ▼ Sell | Open Market | 74 | $889 | 10/13/2021 |
| Breedlove Mark H. | ▼ Sell | Other | 44,806 | — | 10/13/2021 |
| Breedlove Mark H. | ▼ Sell | Other | 36,714 | — | 10/13/2021 |
| Breedlove Mark H. | ▼ Sell | Other | 225,281 | — | 10/13/2021 |
| Breedlove Mark H. | ▼ Sell | Other | 93,296 | — | 10/13/2021 |
| Breedlove Mark H. | ▼ Sell | Other | 4,354 | $139 | 10/13/2021 |
| Breedlove Mark H. | ▼ Sell | Open Market | 12 | $141 | 10/13/2021 |
| Lisa Ricciardi | ▲ Buy | Open Market | 12,500 | $150K | 10/13/2021 |
| O'Brien James Michael | ▲ Buy | Open Market | 5,000 | $60K | 10/13/2021 |
| Golden Seeds Cognition Therapeutics LLC | ▼ Sell | Other | 311,706 | — | 10/13/2021 |
| Peggy Wallace | ▲ Buy | Open Market | 3,000 | $36K | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 418,926 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 245,029 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 78,298 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 255,765 | — | 10/13/2021 |
| BIOS Memory SPV I, LP | ▼ Sell | Other | 1,424,014 | — | 10/13/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Cognition Therapeutics Sets FDA Type C Meeting for Oct. 20
Cognition Therapeutics announced it will hold a Type C meeting with the FDA on October 20 regarding the planned trial of zervimesine. This regulatory step is a key milestone for the drug's development path. The company's stock currently trades within a wide 52-week range, reflecting the uncertainty typical of clinical-stage biotech firms.
Cognition Therapeutics Sets FDA Type C Meeting for Oct. 20. Cognition Therapeutics announced it will hold a Type C meeting with the FDA on October 20 regarding the planned trial of zervimesine. This regulatory step is a key milestone for the drug's development path. The company's stock currently trades within a wide 52-week range, reflecting the uncertainty typical of clinical-stage biotech firms.